2002 LIGAND PROXY

Company

LIGAND PHARMACEUTICALS INC

Filed

April 12, 2002

Period of Report

May 15, 2002

Accession Number

0000886163-02-000006

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →